AIM IMMUNOTECH INC. Interest Expense
AIM IMMUNOTECH INC. (AIM) reported Interest Expense of $295.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-07
- AIM IMMUNOTECH INC. interest expense for the quarter ending 2026-06-30 was $295.00K, a 97.99% increase year-over-year.
- AIM IMMUNOTECH INC. interest expense for the quarter ending 2026-03-31 was $304.00K, a 145.16% increase year-over-year.
- AIM IMMUNOTECH INC. interest expense for the quarter ending 2025-12-31 was $391.00K, a 196.21% increase year-over-year.
- AIM IMMUNOTECH INC. interest expense for the quarter ending 2025-09-30 was $148.00K, a 26.73% decline year-over-year.
- AIM IMMUNOTECH INC. interest expense for fiscal 2025 was $812.00K, a 38.80% increase from fiscal 2024.
- AIM IMMUNOTECH INC. interest expense for fiscal 2024 was $585.00K.
- AIM IMMUNOTECH INC. interest expense for fiscal 2021 was $67.00K, a 90.03% decline from fiscal 2020.
- AIM IMMUNOTECH INC. interest expense for fiscal 2020 was $672.00K, a 57.38% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $295.00K 10-Q · filed 2026-08-07 | $631.00K 10-Q · filed 2026-08-07 | $990.00K derived: sum of 3 quarters · filed 2026-08-07 | $1.14M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | $304.00K 10-Q · filed 2026-05-15 | $695.00K derived: sum of 2 quarters · filed 2026-05-15 | $843.00K derived: sum of 3 quarters · filed 2026-05-15 | $992.00K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | $391.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $539.00K derived: sum of 2 quarters · filed 2026-03-27 | $688.00K derived: sum of 3 quarters · filed 2026-08-07 | $812.00K 10-K · filed 2026-03-27 | ||
| 2025-09-30 | $148.00K 10-Q · filed 2025-11-17 | $297.00K derived: sum of 2 quarters · filed 2026-08-07 | $421.00K 10-Q · filed 2025-11-17 | $553.00K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | $149.00K 10-Q · filed 2026-08-07 | $273.00K 10-Q · filed 2026-08-07 | $405.00K derived: sum of 3 quarters · filed 2026-08-07 | $607.00K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $124.00K 10-Q · filed 2026-05-15 | $256.00K derived: sum of 2 quarters · filed 2026-05-15 | $458.00K derived: sum of 3 quarters · filed 2026-05-15 | $637.00K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $334.00K derived: sum of 2 quarters · filed 2026-03-27 | $513.00K derived: sum of 3 quarters · filed 2026-03-27 | $585.00K 10-K · filed 2026-03-27 | ||
| 2024-09-30 | $202.00K 10-Q · filed 2025-11-17 | $381.00K derived: sum of 2 quarters · filed 2025-11-17 | $453.00K 10-Q · filed 2025-11-17 | |||
| 2024-06-30 | $179.00K 10-Q · filed 2025-08-14 | $251.00K 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | $72.00K 10-Q · filed 2025-05-15 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $19.00K derived: sum of 3 quarters · filed 2023-03-31 | $67.00K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $19.00K derived: sum of 2 quarters · filed 2022-11-14 | $67.00K 10-Q · filed 2022-11-14 | $124.00K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $19.00K 10-Q · filed 2022-08-15 | $67.00K 10-Q · filed 2022-08-15 | $124.00K derived: sum of 3 quarters · filed 2022-08-15 | $175.00K derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $50.00K 10-Q · filed 2022-05-13 | $105.00K derived: sum of 2 quarters · filed 2022-05-13 | $156.00K derived: sum of 3 quarters · filed 2022-05-13 | $405.00K derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $106.00K derived: sum of 2 quarters · filed 2022-03-31 | $355.00K derived: sum of 3 quarters · filed 2022-03-31 | $672.00K 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $51.00K 10-Q · filed 2021-11-15 | $300.00K derived: sum of 2 quarters · filed 2021-11-15 | $617.00K 10-Q · filed 2021-11-15 | $955.00K derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $249.00K 10-Q · filed 2021-08-16 | $571.00K 10-Q · filed 2021-08-16 | $904.00K derived: sum of 3 quarters · filed 2021-08-16 | $947.78K derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $322.00K 10-Q · filed 2021-05-17 | $655.00K derived: sum of 2 quarters · filed 2021-05-17 | $698.78K derived: sum of 3 quarters · filed 2021-05-17 | $744.72K derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $376.78K derived: sum of 2 quarters · filed 2021-03-31 | $422.72K derived: sum of 3 quarters · filed 2021-03-31 | $427.00K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $43.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $89.72K derived: sum of 2 quarters · filed 2019-11-14 | $94.00K 10-Q · filed 2019-11-14 | -$4.00M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2019-06-30 | $45.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $50.22K 10-Q · filed 2019-08-14 | -$4.05M derived: sum of 3 quarters · filed 2019-08-14 | $251.22K derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2019-03-31 | $4.28K 10-Q · filed 2019-05-15 | -$4.09M derived: sum of 2 quarters · filed 2019-05-15 | $205.28K derived: sum of 3 quarters · filed 2019-05-15 | |||
| 2018-12-31 | -$4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $201.00K derived: sum of 2 quarters · filed 2019-04-01 | $201.00K 10-K · filed 2019-04-01 | |||
| 2018-09-30 | $4.30M 10-Q · filed 2018-11-14 | $4.30M 10-Q · filed 2018-11-14 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $1.00K derived: sum of 2 quarters · filed 2017-03-31 | $1.00K derived: sum of 3 quarters · filed 2017-03-31 | $3.00K 10-K · filed 2017-03-31 | ||
| 2015-09-30 | $1.00K 10-Q · filed 2016-11-14 | $1.00K derived: sum of 2 quarters · filed 2016-11-14 | $3.00K 10-Q · filed 2016-11-14 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $2.00K 10-Q · filed 2016-08-15 | ||||
| 2015-03-31 | $2.00K 10-Q · filed 2016-05-16 | |||||
| 2014-12-31 | $11.00K 10-K · filed 2017-03-31 | |||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-09 | $160.00K derived: sum of 2 quarters · filed 2016-03-29 | $114.00K derived: sum of 3 quarters · filed 2016-03-29 | -$33.00K derived: sum of 4 quarters · filed 2016-03-29 | ||
| 2013-12-31 | $160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $114.00K derived: sum of 2 quarters · filed 2016-03-29 | -$33.00K derived: sum of 3 quarters · filed 2016-03-29 | $16.00K 10-K · filed 2016-03-29 | ||
| 2013-09-30 | -$46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$193.00K derived: sum of 2 quarters · filed 2013-11-08 | -$144.00K 10-Q · filed 2013-11-08 | -$52.00K derived: sum of 4 quarters · filed 2015-03-19 | ||
| 2013-06-30 | -$147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$98.00K 10-Q · filed 2013-08-09 | -$6.00K derived: sum of 3 quarters · filed 2015-03-19 | -$41.00K derived: sum of 4 quarters · filed 2015-03-19 | ||
| 2013-03-31 | $49.00K 10-Q · filed 2014-05-09 | $141.00K derived: sum of 2 quarters · filed 2015-03-19 | $106.00K derived: sum of 3 quarters · filed 2015-03-19 | $62.00K derived: sum of 4 quarters · filed 2015-03-19 | ||
| 2012-12-31 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $57.00K derived: sum of 2 quarters · filed 2015-03-19 | $13.00K derived: sum of 3 quarters · filed 2015-03-19 | $24.00K 10-K · filed 2015-03-19 | ||
| 2012-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$79.00K derived: sum of 2 quarters · filed 2013-11-08 | -$68.00K 10-Q · filed 2013-11-08 | $68.00K 10-Q · filed 2012-11-02 | -$48.00K derived: sum of 4 quarters · filed 2014-03-14 | |
| 2012-06-30 | -$44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$33.00K 10-Q · filed 2013-08-09 | $12.00K 10-Q · filed 2012-08-08 | -$13.00K derived: sum of 3 quarters · filed 2014-03-14 | -$4.00K derived: sum of 4 quarters · filed 2014-03-14 | |
| 2012-03-31 | $11.00K 10-Q · filed 2013-05-08 | $31.00K derived: sum of 2 quarters · filed 2014-03-14 | $40.00K derived: sum of 3 quarters · filed 2014-03-14 | $46.00K derived: sum of 4 quarters · filed 2014-03-14 | ||
| 2011-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $29.00K derived: sum of 2 quarters · filed 2014-03-14 | $35.00K derived: sum of 3 quarters · filed 2014-03-14 | $41.00K 10-K · filed 2014-03-14 | ||
| 2011-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $15.00K derived: sum of 2 quarters · filed 2012-11-02 | $21.00K 10-Q · filed 2012-11-02 | |||
| 2011-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $12.00K 10-Q · filed 2012-08-08 | ||||
| 2011-03-31 | $6.00K 10-Q · filed 2012-05-07 | |||||
| 2010-12-31 | $11.00K 10-K · filed 2013-03-18 | |||||
| 2009-12-31 | $0.00 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |